| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 144.79▲ | 145.23▼ | 145.29▼ | 146.64▼ | 144.91▼ |
| MA10 | 144.83▼ | 145.52▼ | 144.98▼ | 147.93▼ | 142.73▲ |
| MA20 | 145.08▼ | 145.10▼ | 145.68▼ | 145.40▼ | 138.00▲ |
| MA50 | 145.41▼ | 146.18▼ | 148.52▼ | 142.64▲ | 128.49▲ |
| MA100 | 144.99▼ | 149.06▼ | 146.10▼ | 137.49▲ | 130.98▲ |
| MA200 | 145.63▼ | 146.12▼ | 143.15▲ | 126.75▲ | 116.75▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.027▼ | 0.071▲ | 0.080▲ | -0.267▼ | 0.580▲ |
| RSI | 43.176▼ | 42.059▼ | 41.101▼ | 50.554▲ | 58.585▲ |
| STOCH | 30.191 | 53.189 | 59.051 | 49.071 | 59.939 |
| WILL %R | -77.273▼ | -47.641 | -69.665 | -53.242 | -37.699 |
| CCI | -61.923 | -31.787 | -52.968 | -21.032 | 112.850▲ |
| RSI | $NBIX RSI(14) Crossed Above 50 | Set Alert |
|
Wednesday, November 12, 2025 04:09 AM
US biotech Neurocrine Biosciences (Nasdaq: NBIX) said its Phase II trial of NBI-1070770 in adults with major depressive disorder failed to meet the primary endpoint against placebo, though the drug ...
|
|
Tuesday, November 11, 2025 01:12 PM
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that members of the management team will participate at the following investor conferences: ...
|
|
Tuesday, November 11, 2025 08:51 AM
Neurocrine's Phase 2 trial of NBI-1070770 in major depressive disorder missed its main goal but showed good safety and strong Q3 financial results.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 142.99 | 146.375 | 142.99 | 144.86 | 642,910 |
| 13/11/25 | 146.01 | 148.835 | 143.91 | 144.165 | 922,569 |
| 12/11/25 | 147.40 | 148.035 | 145.41 | 146.85 | 1,155,779 |
| 11/11/25 | 147.50 | 149.42 | 145.00 | 147.29 | 1,352,557 |
| 10/11/25 | 152.97 | 154.10 | 146.02 | 150.02 | 964,285 |
| 07/11/25 | 154.25 | 154.50 | 148.97 | 152.37 | 1,431,361 |
| 06/11/25 | 153.86 | 155.64 | 152.86 | 154.80 | 944,420 |
| 05/11/25 | 147.70 | 157.67 | 147.70 | 153.75 | 2,937,687 |
| 04/11/25 | 142.35 | 143.87 | 140.82 | 143.19 | 744,569 |
| 03/11/25 | 142.62 | 144.98 | 139.46 | 141.96 | 764,238 |
|
|
||||
|
|
||||
|
|